CIK 0000926617
- Non-accelerated filer
- Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330595156
- Phone
- +1 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 80 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-19 | SCHREIBER DAVID Director | Grant or award | +4,031 | 171,521 | ||
| 2020-09-08 | SCHREIBER DAVID Director | Sale | −50,000 | $2.78 | $139K | 185,018 |
| 2020-03-19 | SCHREIBER DAVID Director | Grant or award | +70,113 | 235,018 | ||
| 2019-06-03 | SCHREIBER DAVID Director | Sale | −10,000 | $1.10 | $11K | 164,905 |
| 2019-03-26 | SCHREIBER DAVID Director | Grant or award | +37,500 | 174,905 | ||
| 2019-03-07 | SCHREIBER DAVID Director | Sale | −30,000 | $1.00 | $30K | 137,405 |
| 2018-04-13 | SCHREIBER DAVID Director | Grant or award | +79,200 | 167,405 | ||
| 2017-03-23 | SCHREIBER DAVID Director | Grant or award | +26,250 | 88,205 | ||
| 2016-03-17 | SCHREIBER DAVID Director | Grant or award | +30,909 | 59,000 | ||
| 2015-07-13 | SCHREIBER DAVID Director | Grant or award | +28,091 | 28,091 |
Page 1 of 1 · 10 trades